Claritev Corporation Announces Strategic Investment In Klaim To Launch A Co-Branded Payment Acceleration Service Within Claritev's Provider Network

Author: Benzinga Newsdesk | October 27, 2025 04:03pm

Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a global leader in healthcare analytics and claims analysis, today announced a strategic investment in Klaim, Inc., an AI-driven healthcare payment-acceleration solutions provider. The investment will help fund the launch of a co-branded Payment Acceleration Service integrated within Claritev's extensive provider network, helping healthcare organizations gain faster and more predictable access to reimbursements across the U.S. and MENA regions.

This investment and relationship strengthen Claritev's strategic expansion in the MENA region while supporting Klaim's expansion across the U.S. Together, the companies can combine Claritev's deep payor-provider infrastructure and ACE analytics platformwith Klaim's proven payment-acceleration technology, aiming to set a new benchmark for liquidity access and operational efficiency in healthcare finance.

The Claritev–Klaim Payment Acceleration platform is designed to allow eligible healthcare providers in the U.S. and MENA region to convert pending insurance claims into near-instant liquidity, reducing the typical 30–120-day reimbursement cycle.

As part of the collaboration, Klaim will leverage Claritev's Advanced Code Editing (ACE) technology for claim coding intelligence to enable evaluation of claims qualified for funding.

Additional key benefits to participating providers are anticipated to include:

• Certainty of payment for qualifying claims and reduced risk of cash flow gaps due to denials or delays
• Flexible usage as providers can choose the volume of claims to accelerate, based on their working capital needs
• Reduced administrative burden as Klaim undertakes reconciliation and payor follow-up for accelerated claims
• Scalable access, making the platform suitable for small clinics, large hospitals and multi-specialty networks

"Our investment in Klaim reflects Claritev's commitment to modernizing provider cash flow and strengthening financial resilience across the healthcare system," said Will Mintz, Chief Strategy Officer at Claritev. "By combining Claritev's trusted provider relationships and ACE technology with Klaim's fintech infrastructure, we're helping providers get paid faster and operate with greater confidence."

"This relationship is about unlocking liquidity at scale for healthcare providers," added Karim Dakki, Co-Founder & CEO of Klaim. "Together with Claritev, we're bringing a data-driven solution that turns delayed reimbursements into predictable cash flow, helping practices stay focused on delivering care rather than chasing payments. The investment also marks the beginning of Klaim's global restructuring, which is anticipated to bring together Klaim Middle East (under Klaim Holdings Limited) and Klaim, Inc. under a planned global holding company."

Posted In: CTEV